Instil Bio, Inc.
NASDAQ: TIL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Bronson Crouch
- Employees
- 14
- Headquarters
- Dallas, United States
- IPO year
- 2021
- Market cap
- $51.8M
- Website
- https://instilbio.com
Loading TIL…
Loading profile data…Frequently asked questions about TIL
What does Instil Bio, Inc. (TIL) do?
Instil Bio, Inc. operates as a clinical-stage biopharmaceutical firm, concentrating its efforts on devising novel therapeutic options for individuals battling cancer. A cornerstone of their research involves the advancement of autologous tumor-infiltrating lymphocyte (TIL) cell therapies. Their developmental portfolio features ITIL-168, currentl...
Where does TIL trade?
Instil Bio, Inc. (TIL) trades on the NASDAQ Global Select.
What sector is TIL in?
Instil Bio, Inc. (TIL) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Instil Bio, Inc.?
Bronson Crouch is the chief executive officer of Instil Bio, Inc. (TIL).
Where is Instil Bio, Inc. headquartered?
Instil Bio, Inc. is headquartered in United States.
Does TIL pay a dividend?
Instil Bio, Inc. (TIL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TIL go public?
Instil Bio, Inc. (TIL) completed its initial public offering in 2021.